Skip to content
OpenCapital
Get started

Rallybio Corporation RLYB Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$212.0KBeat by $145.3K
EPS-$0.14Beat by $0.11
Revenue estimate$66.7K
EPS estimate-$0.25

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$216.5K
EPS estimate-$1.28

Versus estimates

Revenue

Q1 2026$212.0KIn lineQ4 2025$222.0KBeat by $122.0K
Q3 2025$212.0KBeat by $145.3K
Q2 2025$212.0KBeat by $145.3KQ1 2025$212.0KQ4 2024$38.0KMiss by $111.5K

Diluted EPS

Q1 2026-$1.46Miss by $0.26Q4 2025-$1.28Miss by $0.04
Q3 2025-$0.14Beat by $0.11
Q2 2025-$0.22Miss by $0.02Q1 2025-$0.21In lineQ4 2024-$0.25Beat by $0.02

Ask the moment Rallybio Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rallybio Corporation report Q3 2025 earnings?
Rallybio Corporation (RLYB) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Rallybio Corporation's Q3 2025 revenue and EPS?
Rallybio Corporation reported revenue of $212.0K and eps of $-0.14 for Q3 2025.
Did Rallybio Corporation beat estimates in Q3 2025?
Revenue beat the consensus estimate of $66.7K by $145.3K. EPS beat the consensus estimate of $-0.25 by $0.11.
How did Rallybio Corporation's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 29.1% from $299.0K a year earlier and eps grew 46.2% from $-0.26.
Where can I find Rallybio Corporation's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001739410-25-000131) and the 10-Q periodic report (0001739410-25-000132) directly on SEC EDGAR. The filing index links above go to sec.gov.